We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVGI icon
3776
Commercial Vehicle Group
CVGI
$132M
$15K ﹤0.01%
2,043
+1,931
+1,724% +$14.6K
CYRX icon
3777
CryoPort
CYRX
$772M
$15K ﹤0.01%
627
-115
-15% -$2.5K
DMRC icon
3778
Digimarc Corp
DMRC
$169M
$15K ﹤0.01%
743
-1,333
-64% -$26.9K
DYN icon
3779
Dyne Therapeutics
DYN
$4.8B
$15K ﹤0.01%
1,273
+538
+73% +$6.99K
ELDN icon
3780
Eledon Pharmaceuticals
ELDN
$273M
$15K ﹤0.01%
6,251
+4,353
+229% +$11.7K
FHTX icon
3781
Foghorn Therapeutics
FHTX
$372M
$15K ﹤0.01%
2,364
+1,112
+89% +$7.28K
FISI icon
3782
Financial Institutions
FISI
$823M
$15K ﹤0.01%
791
+402
+103% +$9.42K
FXI icon
3783
iShares China Large-Cap ETF
FXI
$4.16B
$15K ﹤0.01%
506
-3,928
-89% -$118K
GCMG icon
3784
GCM Grosvenor
GCMG
$2.81B
$15K ﹤0.01%
1,901
+166
+10% +$1.38K
GLSI icon
3785
Greenwich LifeSciences
GLSI
$247M
$15K ﹤0.01%
1,101
+1,049
+2,017% +$16.6K
GPMT
3786
Granite Point Mortgage Trust
GPMT
$57.4M
$15K ﹤0.01%
3,071
+2,632
+600% +$15.3K
HLLY icon
3787
Holley
HLLY
$377M
$15K ﹤0.01%
5,556
+1,592
+40% +$4.07K
ISSC icon
3788
Innovative Solutions & Support
ISSC
$412M
$15K ﹤0.01%
2,011
+1,567
+353% +$12.7K
IVR icon
3789
Invesco Mortgage Capital
IVR
$805M
$15K ﹤0.01%
1,334
-772
-37% -$9.95K
JQC icon
3790
Nuveen Credit Strategies Income Fund
JQC
$708M
$15K ﹤0.01%
+3,000
New +$15.7K
KALA icon
3791
KALA BIO
KALA
$18.3M
$15K ﹤0.01%
20
+18
+900% +$15.7K
KNDI
3792
Kandi Technologies Group
KNDI
$63M
$15K ﹤0.01%
5,157
-25,113
-83% -$63.6K
KNTK icon
3793
Kinetik
KNTK
$4.3B
$15K ﹤0.01%
473
-50
-10% -$1.53K
LCTX icon
3794
Lineage Cell Therapeutics
LCTX
$271M
$15K ﹤0.01%
9,968
-1,376
-12% -$1.92K
LFCR icon
3795
Lifecore Biomedical
LFCR
$179M
$15K ﹤0.01%
3,885
-30,521
-89% -$170K
MIRM icon
3796
Mirum Pharmaceuticals
MIRM
$6.14B
$15K ﹤0.01%
644
-1,685
-72% -$38.4K
MOFG
3797
DELISTED
MidWestOne Financial Group
MOFG
$15K ﹤0.01%
622
-181
-23% -$5.34K
MTN icon
3798
Vail Resorts
MTN
$5.28B
$15K ﹤0.01%
66
-2,043
-97% -$492K
MTW icon
3799
Manitowoc
MTW
$746M
$15K ﹤0.01%
868
-2,529
-74% -$37.9K
OPAD icon
3800
Offerpad Solutions
OPAD
$21.5M
$15K ﹤0.01%
192
-43
-18% -$4.27K
150 151
152
153 154

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.